RMD Jan 2025 180.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:14AM EDT. Market open.
Loading interactive chart...
- GlobeNewswire
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2024 on Thursday, August 1, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Location: http://investor.resmed.com Date:
- Zacks
Omnicell (OMCL) Banks on Product Launches, Global Growth
Omnicell (OMCL) remains a key player in automating and modernizing global medication management infrastructure.
- Zacks
Zacks.com featured highlights include ResMed, Badger Meter, Leidos and Ingersoll Rand
ResMed, Badger Meter, Leidos and Ingersoll Rand are part of the Zacks Screen of the Week article.
© 2024 Yahoo. All rights reserved.